First Time Loading...

Becton Dickinson and Co
NYSE:BDX

Watchlist Manager
Becton Dickinson and Co Logo
Becton Dickinson and Co
NYSE:BDX
Watchlist
Price: 234.12 USD 0.42% Market Closed
Updated: Apr 20, 2024

Intrinsic Value

Becton, Dickinson & Co. is a medical technology company. [ Read More ]

The intrinsic value of one BDX stock under the Base Case scenario is 280.57 USD. Compared to the current market price of 234.12 USD, Becton Dickinson and Co is Undervalued by 17%.

Key Points:
BDX Intrinsic Value
Base Case
280.57 USD
Undervaluation 17%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Becton Dickinson and Co

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BDX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Becton Dickinson and Co

Provide an overview of the primary business activities
of Becton Dickinson and Co.

What unique competitive advantages
does Becton Dickinson and Co hold over its rivals?

What risks and challenges
does Becton Dickinson and Co face in the near future?

Has there been any significant insider trading activity
in Becton Dickinson and Co recently?

Summarize the latest earnings call
of Becton Dickinson and Co.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Becton Dickinson and Co.

Provide P/S
for Becton Dickinson and Co.

Provide P/E
for Becton Dickinson and Co.

Provide P/OCF
for Becton Dickinson and Co.

Provide P/FCFE
for Becton Dickinson and Co.

Provide P/B
for Becton Dickinson and Co.

Provide EV/S
for Becton Dickinson and Co.

Provide EV/GP
for Becton Dickinson and Co.

Provide EV/EBITDA
for Becton Dickinson and Co.

Provide EV/EBIT
for Becton Dickinson and Co.

Provide EV/OCF
for Becton Dickinson and Co.

Provide EV/FCFF
for Becton Dickinson and Co.

Provide EV/IC
for Becton Dickinson and Co.

Show me price targets
for Becton Dickinson and Co made by professional analysts.

What are the Revenue projections
for Becton Dickinson and Co?

How accurate were the past Revenue estimates
for Becton Dickinson and Co?

What are the Net Income projections
for Becton Dickinson and Co?

How accurate were the past Net Income estimates
for Becton Dickinson and Co?

What are the EPS projections
for Becton Dickinson and Co?

How accurate were the past EPS estimates
for Becton Dickinson and Co?

What are the EBIT projections
for Becton Dickinson and Co?

How accurate were the past EBIT estimates
for Becton Dickinson and Co?

Compare the revenue forecasts
for Becton Dickinson and Co with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Becton Dickinson and Co and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Becton Dickinson and Co against its competitors.

Analyze the profit margins
(gross, operating, and net) of Becton Dickinson and Co compared to its peers.

Compare the P/E ratios
of Becton Dickinson and Co against its peers.

Discuss the investment returns and shareholder value creation
comparing Becton Dickinson and Co with its peers.

Analyze the financial leverage
of Becton Dickinson and Co compared to its main competitors.

Show all profitability ratios
for Becton Dickinson and Co.

Provide ROE
for Becton Dickinson and Co.

Provide ROA
for Becton Dickinson and Co.

Provide ROIC
for Becton Dickinson and Co.

Provide ROCE
for Becton Dickinson and Co.

Provide Gross Margin
for Becton Dickinson and Co.

Provide Operating Margin
for Becton Dickinson and Co.

Provide Net Margin
for Becton Dickinson and Co.

Provide FCF Margin
for Becton Dickinson and Co.

Show all solvency ratios
for Becton Dickinson and Co.

Provide D/E Ratio
for Becton Dickinson and Co.

Provide D/A Ratio
for Becton Dickinson and Co.

Provide Interest Coverage Ratio
for Becton Dickinson and Co.

Provide Altman Z-Score Ratio
for Becton Dickinson and Co.

Provide Quick Ratio
for Becton Dickinson and Co.

Provide Current Ratio
for Becton Dickinson and Co.

Provide Cash Ratio
for Becton Dickinson and Co.

What is the historical Revenue growth
over the last 5 years for Becton Dickinson and Co?

What is the historical Net Income growth
over the last 5 years for Becton Dickinson and Co?

What is the current Free Cash Flow
of Becton Dickinson and Co?

Financials

Balance Sheet Decomposition
Becton Dickinson and Co

Current Assets 8.2B
Cash & Short-Term Investments 1.2B
Receivables 2.3B
Other Current Assets 4.7B
Non-Current Assets 44.1B
PP&E 6.6B
Intangibles 35.2B
Other Non-Current Assets 2.3B
Current Liabilities 7.5B
Accounts Payable 5.5B
Other Current Liabilities 2B
Non-Current Liabilities 19.4B
Long-Term Debt 14.1B
Other Non-Current Liabilities 5.3B
Efficiency

Earnings Waterfall
Becton Dickinson and Co

Revenue
19.5B USD
Cost of Revenue
-11.4B USD
Gross Profit
8.1B USD
Operating Expenses
-6B USD
Operating Income
2.1B USD
Other Expenses
-832m USD
Net Income
1.2B USD

Free Cash Flow Analysis
Becton Dickinson and Co

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

BDX Profitability Score
Profitability Due Diligence

Becton Dickinson and Co's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
52/100
Profitability
Score

Becton Dickinson and Co's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

BDX Solvency Score
Solvency Due Diligence

Becton Dickinson and Co's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
50/100
Solvency
Score

Becton Dickinson and Co's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BDX Price Targets Summary
Becton Dickinson and Co

Wall Street analysts forecast BDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BDX is 284.11 USD with a low forecast of 242.4 USD and a high forecast of 330.75 USD.

Lowest
Price Target
242.4 USD
4% Upside
Average
Price Target
284.11 USD
21% Upside
Highest
Price Target
330.75 USD
41% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

BDX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

BDX Price
Becton Dickinson and Co

1M 1M
-2%
6M 6M
-9%
1Y 1Y
-11%
3Y 3Y
-4%
5Y 5Y
+13%
10Y 10Y
+140%
Annual Price Range
234.12
52w Low
231.01
52w High
283.59
Price Metrics
Average Annual Return 5.75%
Standard Deviation of Annual Returns 12.11%
Max Drawdown -30%
Shares Statistics
Market Capitalization 67.9B USD
Shares Outstanding 288 902 016
Percentage of Shares Shorted 1.01%

BDX Return Decomposition
Main factors of price return

What is price return decomposition?

BDX News

Other Videos

Company Profile

Becton Dickinson and Co Logo
Becton Dickinson and Co

Country

United States of America

Industry

Health Care

Market Cap

67.9B USD

Dividend Yield

1.62%

Description

Becton, Dickinson & Co. is a medical technology company. The company is headquartered in Franklin Lakes, New Jersey and currently employs 75,000 full-time employees. The firm operates through three business segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Contact

NEW JERSEY
Franklin Lakes
One Becton Drive
+12018476800.0
https://www.bd.com/

IPO

1963-09-25

Employees

75 000

Officers

President, CEO & Chairman
Mr. Thomas E. Polen Jr.
Executive VP & CFO
Mr. Christopher J. DelOrefice
Executive VP & Chief People Officer
Ms. Shana Carol Neal
Executive VP & President of Life Sciences Segment
Mr. David B. Hickey
Executive VP & President of Medical segment
Mr. Michael Garrison
Senior VP, Controller & Chief Accounting Officer
Mr. Thomas J. Spoerel
Show More
Executive VP & Chief Technology Officer
Ms. Elizabeth McCombs
Senior VP, Chief Scientific Officer & Co-Chair of Scientific Advisory Board
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.
Executive VP of Technology & Global Services and Chief Information Officer
Ms. Denise Russell Fleming
Head of Investor Relations
Mr. Greg Rodetis
Show Less

See Also

Discover More
What is the Intrinsic Value of one BDX stock?

The intrinsic value of one BDX stock under the Base Case scenario is 280.57 USD.

Is BDX stock undervalued or overvalued?

Compared to the current market price of 234.12 USD, Becton Dickinson and Co is Undervalued by 17%.